BioELife Corp.
LITH · OTC
12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $1 | $1 | $0 | $0 |
| Gross Profit | -$1 | -$1 | -$2 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $74 | $81 | $104 | $61 |
| SG&A Expenses | $74 | $125 | $104 | $61 |
| Sales & Mktg Exp. | $0 | $44 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $74 | $125 | $104 | $61 |
| Operating Income | -$74 | -$125 | -$104 | -$61 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$263 | -$122 | -$106 | -$21 |
| Pre-Tax Income | -$337 | -$247 | -$210 | -$82 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$337 | -$247 | -$210 | -$82 |
| % Margin | – | – | – | – |
| EPS | -0.13 | -0.1 | -0.093 | -0.043 |
| % Growth | -30% | -8.1% | -113.1% | – |
| EPS Diluted | -0.13 | -0.1 | -0.093 | -0.043 |
| Weighted Avg Shares Out | 2,606 | 2,451 | 2,266 | 1,894 |
| Weighted Avg Shares Out Dil | 2,606 | 2,451 | 2,266 | 1,894 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $83 | $122 | $106 | $39 |
| Depreciation & Amortization | $74 | $125 | $104 | -$123 |
| EBITDA | -$74 | -$125 | -$104 | -$61 |
| % Margin | – | – | – | – |